Midatech appoints Dr Jim Phillips as chief executive
pharmafile | September 16, 2013 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |Â Â Â
Midatech, a firm specialising in nanomedicines, has appointed Dr Jim Philips as its new chief executive.
Dr Philips has over 25 years of senior management and board level experience in public and private companies across Europe, the US and Australia.
Dr Phillips joins Midatech from Healthcare Brands International Ltd (HBI), the UK consumer healthcare company, where he has been chief executive since 2010.
Before joining HBI, Dr Phillips was head of Vantia, a pharmaceutical company developing novel, small molecule drugs.
Dr Phillips has also held senior roles in drug and business development in Novartis and Johnson & Johnson.






